entertainment -WSS

entertainment

author：explore 2025-10-02 22:24:56 - browse：3442

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Novo Nordisk obesity pill bests Wegovy in early trial

focus

WSS

A Q&A with Aletha Maybank, AMA’s chief health equity officer

IVF, abortion rights issues kick off Biden’s State of the Union

What it’s like to watch children die of measles

FDA does about

Change Healthcare cyberattack prompts Medicare loan program

First medicine developed to treat MASH expected to be approved soon

hotspot

entertainment

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Malaria cases in Florida and Texas: Here’s what you need to know

Obesity now affects over 1 billion people worldwide, study finds

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Apple is now the first public company to be valued at $3 trillion

With psoriasis trial ahead, Alumis raises $259 million

Peter Hotez and the public health issue of online harassment

Kenai launches with $82 million for Parkinson’s stem cell therapy

knowledge

CDC marks new Covid

How to fix the rural physician shortage in the U.S.

The drug industry has found itself all alone in Washington

With psoriasis trial ahead, Alumis raises $259 million

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

leisure time

explore

focus

hotspot